A Multicenter Prospective Study of Iptacopan in the Treatment of Refractory/Relapsed Autoimmune Hemolytic Anemia (AIHA)

NCT06847607 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

AIHA - Warm Autoimmune Hemolytic Anemia
AIHA - Cold Autoimmune Hemolytic Anemia

Interventions

DRUG: Iptacopan

Sponsor

Bing Han